Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05004051 · ClinicalTrials.gov registry record
ViTAA Registry Pre- and Post-Operative Monitoring for Endovascular Aortic Aneurysm Repair and Serial Monitoring for AAA
A clinical trial of Abdominal Aortic Aneurysms, sponsored by ViTAA Medical Solutions.
- Recruiting
- Registry status
- 200
- Enrollment target
- 8
- Study locations
NCT05004051: Recruiting study of Abdominal Aortic Aneurysms, sponsored by ViTAA Medical Solutions.
NCT05004051 is a study of Abdominal Aortic Aneurysms that is actively recruiting participants, run by ViTAA Medical Solutions. The registered enrollment target is 200 participants, above the 163-participant average among 5 other Abdominal Aortic Aneurysms trials with a reported enrollment target (23% higher). The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05004051, a study of Abdominal Aortic Aneurysms, is actively recruiting participants, sponsored by ViTAA Medical Solutions.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 8
- Study locations
Study Summary
This is a Prospective Registry study to collect imaging and clinical data both on patients with aortic aneurysm disease undergoing serial monitoring and on patients pre and post-endovascular repair, using ViTAA (The Sponsor) aortic mapping technology.
Primary Outcome
* Critical growth defined as an increase of \> 0.5 cm in any of the three growth measurements below * Critical growth defined as an increase of \> 0.5 cm in aortic diameter. * Critical growth defined as an increase of \> 0.5 cm in ILT. * Critical growth defined as an increase of \> 0.5 cm in aneurysm sac volume.
Conditions Studied
Interventions
- DEVICE ViTAA Analysis
Study Locations (8)
Quebec
- CHUM - Centre Hospitalier de l'Université de Montréal - Montreal
- MUHC - McGill University Health Centre - Montreal
Alabama
- UAB - University of Alabama in Birmingham Hospital - Birmingham
Massachusetts
- MGH - Massachusetts General Hospital Fireman Vascular Center - Boston
North Carolina
- UNC - University of North Carolina at Chapel Hill - Chapel Hill
Washington
- University of Washington - Seattle
Alberta
- UCGY - University of Calgary, Peter Lougheed Center - Calgary
Ontario
- UHN - University Health Network - Toronto General Hospital - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-12-15 |
| Est. Completion | 2026-12-31 |
What NCT05004051 shows while recruiting
NCT05004051 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 163-participant average among 5 other Abdominal Aortic Aneurysms trials with a reported enrollment target (23% higher).
The record links to 1 condition, with Abdominal Aortic Aneurysms appearing as the primary indexed condition, and to 1 intervention - of which ViTAA Analysis is the first listed.
NCT05004051 lists 8 locations in 7 states (Quebec, Alabama, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT05004051 about?
NCT05004051 is a clinical study titled "ViTAA Registry Pre- and Post-Operative Monitoring for Endovascular Aortic Aneurysm Repair and Serial Monitoring for AAA". This is a Prospective Registry study to collect imaging and clinical data both on patients with aortic aneurysm disease undergoing serial monitoring and on patients pre and post-endovascular repair, using ViTAA (The Sponsor) aortic mapping technology.
What is the current status of trial NCT05004051?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2021-12-15. Estimated completion is 2026-12-31.
What conditions does trial NCT05004051 study?
This clinical trial studies the following conditions: Abdominal Aortic Aneurysms.
What interventions are being tested in trial NCT05004051?
The interventions under investigation include: ViTAA Analysis (DEVICE).
Who is sponsoring clinical trial NCT05004051?
This trial is sponsored by ViTAA Medical Solutions, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05004051 being conducted?
This trial has 8 study locations across Alabama, Massachusetts, North Carolina, Washington, Alberta. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abdominal Aortic Aneurysms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Physician-Modified Endografts for Complex Aortic Aneurysms and Thoracoabdominal Aneurysm Repair in High-Risk Patients
RECRUITING · NA
-
Physician Modified Endovascular Grafts
RECRUITING · NA
-
Prospective Aneurysm Trial: High Angle Aorfix™ Bifurcated Stent Graft
COMPLETED · NA
-
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
COMPLETED · NA
-
Treovance Stent-Graft With Navitel Delivery System for Patients With Infrarenal Abdominal Aortic Aneurysms
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI